Category: Immucor Inc.
Private equity players Bain Capital, Carlyle Group and KKR & Co. are in the hunt for medical device company Carestream, said to be on the auction block for up to $3.5 billion.
At least 5 major private equity players are vying for medical device company Carestream Health, including Bain Capital, Carlyle Group and KKR & Co., according to Reuters.
Onex Corp. is hoping to unload Carestream, formed in the 2007 spinout of Eastman Kodak Co.'s healthcare business, for up to $3.5 billion, the news service reported.
Immucor agrees to acquire Hologic's Lifecodes transplant diagnostics business in a deal worth up to $95 million, marking the 1st publicly reported acquisition by Immucor since former Medtronic CEO William Hawkins took the corner office.
In-vitro diagnostics maker Immucor (NSDQ:BLUD) signed a definitive agreement to acquire the Lifecodes transplant diagnostics business of Hologic (NSDQ:HOLX) in a deal worth up to $95 million.
Former Medtronic chairman & CEO Bill Hawkins receives more than $8 million in total compensation, including a $3.8 million lump severance payment, following his resignation from the corner office.
Former Medtronic (NYSE:MDT) chairman & CEO received more than $8 million in total compensation for his final year at the medical device titan, including a severance payment of about $3.8 million.
Moody's Investor Services estimates that the impact of the medical device tax for the companies it covers will top $650 million.
The 2.3% tax on revenues slated to go into effect next year for medical device makers could top $650 million for the med-tech companies covered by Moody's Investor Services, according to a report by the ratings agency.
The tax will help slow EBIDTA growth rates for the med-tech sector to between 1% and 4% over the next year to 18 months, according to Moody's, with organic growth rates of between 2% and 3% during that period.
Former Medtronic CEO Bill Hawkins signs on as the inaugural chair for a new private-public med-tech regulatory science partnership for LifeScience Alley.
Former Medtronic (NYSE:MDT) CEO Bill Hawkins will serve as the first chairman of a new private-public partnership aimed at improving development and testing of medical devices.
The partnership includes the Minnesota med-tech community, the FDA's Center for Devices & Radiological Health and the University of Minnesota to establish a regulatory science center in the North Star State.
Thoratec Corp. appoints Immucor CEO and former Medtronic chief William Hawkins to its board of directors.
Cardiac device maker Thoratec Corp. (NSDQ:THOR) appointed former Medtronic (NYSE:MDT) CEO William Hawkins to its board of directors.
The current Immucor Inc. (NSDQ:BLUD) CEO brings more than 30 years of med-tech experience with him to the Pleasanton, Calif.-based boardroom.
The top seven medical device stories for the week of October 3, 2011.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you're still in the know with MassDevice +7.